MA

Mastercard Incorporated

$620.42

+0.65% 2026-10-20

FinancialsS&P 500

1M 3M 6M 1Y 2Y

MASPY

+2.6%

+9.9%

+15.4%

+21.7%

YTD

+9.4%

+10.2%

Live chart

Loading live chart…

Grades vs sector

Momentum

30th pct in sector

D+

12-1 return: +0.4%
Percentile within its GICS sector across the S&P 1500.

Growth

62nd pct in sector

B-

Revenue growth (YoY): +14.1%
Percentile within its GICS sector across the S&P 1500.

Value

4th pct in sector

Forward E/P: 3.7% · EBITDA/EV: 4.0%
Percentile within its GICS sector across the S&P 1500.

Profitability

97th pct in sector

A+

Profit margin: +46.3% · Return on equity: +241.2%
Percentile within its GICS sector across the S&P 1500.

Revisions

Not enough data yet

–

EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Top 15

rank 293 of 499 · 12-1 momentum % 4.2

Momentum Blend

not in the current book

New Highs Growth

not ranked (outside this model's universe or screens)

Conviction 20

not in the current book

News

More news

Is The Market Underpricing Mastercard Stock?

Trefis · 3h ago

AbbVie Named Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team, Launches AbbVie Race to Innovate to Support Immunology Community

PR Newswire · 17h ago

The Access Tax Amazon Imposed on Shopping Agents Just Arrived at Your Bank

Forkast News · 18h ago

Greg Abel's Berkshire Hathaway Owns These 5 Stocks. Here's What $1,000 in Each Could Be Worth by 2030.

Nasdaq · 18h ago

Billion Dollar Boy Group bets B2B is creator marketing’s next big wave

Marketing Dive · Oct 19

Key stats

Market cap$543.5B

P/E (trailing)34.1

P/E (forward)26.9

52-week range464.52 – 624.29

Revenue growth (YoY, latest qtr)+14.1%

Dividend yield0.56%

Analyst consensusStrong Buy (37)

Mean price target$674.25 (+9%)

Valuation and fundamentals

Valuation & fundamentals

Bottom line

Leans expensive

Model read-out from the numbers below, not advice. Score -1 (DCF counts double).

•DCF (base case)above the price by 7%

▼Forward P/E vs sector26.9x vs median 10.2x

•Piotroski F-score4/9

▲Net debt / EBITDA0.6x

•Analyst target+9% (37 analysts)

Discounted cash flow

Bear

$378

-39%

growth 8% · disc. 9.1% · term. 2.0%

Base

$662

+7%

growth 14% · disc. 8.1% · term. 2.5%

Bull

$1,111

+79%

growth 17% · disc. 7.1% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 10% a year for 10 years.

Implied

+10%/yr

FCF, last 3 yrs

+17%/yr

FCF, last 5 yrs

+20%/yr

Revenue, last 3 yrs

+14%/yr

Revenue, last 5 yrs

+16%/yr

Same inputs as the DCF above: trailing free cash flow 16.7B, 8.1% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 0.76 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Financials

P/E (trailing)

sector median 13.0× · 92nd pct

34.1×
pricier

Forward P/E

sector median 10.2× · 99th pct

26.9×
pricier

EV / EBITDA

sector median 10.9× · 95th pct

25.7×
pricier

Price / sales

sector median 2.8× · 88th pct

15.5×
pricier

Price / book

sector median 1.6× · 100th pct

96.9×
pricier

FCF yield

sector median 8.2% · 13th pct

3.1%
pricier

Forward EPS $23.07 vs trailing $18.18 (+27% expected growth). Forward P/E uses analysts' next-12-month estimate.

Backlog (remaining performance obligations)

RPO

$1.3B

as of 2020-12-31

vs a year ago

+0%

YoY

× TTM revenue

0.04×

coverage

18-03

18-06

18-09

18-12

19-12

20-12

Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).

Quality & financial health

Gross margin

–

Operating margin

58.3%

FCF margin

47.6%

Net margin

9.2%

Return on equity

57.4%

Return on invested capital

87.0%

Net debt / EBITDA

0.6×

Current ratio

1.1×

Interest cover

27.4×

Cash conversion (OCF/NI)

5.4×

Piotroski F-score 4/9 · last two fiscal years

✓ Positive net income✗ Positive operating cash flow✗ Return on assets improved✗ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✗ Gross margin improved✓ Asset turnover improved

Analysts

Mean target

$674

+9%

Analysts

Strong Buy

Range

$550–$760

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$32.8B	–	$17.2B
2024	$28.2B	–	$14.3B
2023	$25.1B	–	$11.6B
2022	$22.2B	–	$10.8B
2021	$18.9B	–	$9.1B
2020	$15.3B	–	$6.9B

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +13.8%.

Earnings

Next report: 2026-10-29 · before open · EPS est 5.16

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-07-30	4.78	5.04	+5.5%
2026-04-30	4.41	4.60	+4.2%
2026-01-29	4.24	4.76	+12.3%
2025-10-30	4.31	4.38	+1.5%
2025-07-31	4.02	4.15	+3.1%
2025-05-01	3.56	3.73	+4.8%
2025-01-30	3.69	3.82	+3.5%
2024-10-31	3.75	3.89	+3.9%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$9.3B	+14.1%
2026-03-31	$8.4B	–
2025-12-31	$8.8B	–
2025-09-30	$8.6B	–
2025-06-30	$8.1B	–

Analyst actions

Baird

2026-10-09 · main

Outperform → Outperform
PT $710

RBC Capital

2026-08-31 · main

Outperform → Outperform
PT $696

Wolfe Research

2026-08-25 · main

Outperform → Outperform
PT $740

Truist Securities

2026-08-05 · main

Buy → Buy
PT $633

Cantor Fitzgerald

2026-08-03 · main

Overweight → Overweight
PT $695

UBS

2026-07-31 · main

Buy → Buy
PT $670

Recent dividends

2026-10-09: $0.870 · 2026-07-09: $0.870 · 2026-04-09: $0.870 · 2026-01-09: $0.870 · 2025-10-09: $0.760 · 2025-07-09: $0.760 · 2025-04-09: $0.760 · 2025-01-10: $0.760

Insider trades

Ling Hai

Chief Financial Officer · 2026-10-16

SELL
$2.7M

Genachowski Julius

Director · 2026-10-12

SELL
$218.4K

Genachowski Julius

Director · 2026-10-09

SELL
$216.4K

Genachowski Julius

Director · 2026-10-09

SELL
$590

Sachin J. Mehra

Chief Business Officer · 2026-09-02

SELL
$1.9M

Kirkpatrick Linda Pistecchia

Chief Services Officer · 2026-08-31

SELL
$547.8K

Sachin J. Mehra

Chief Business Officer · 2026-08-20

SELL
$572.1K

Sachin J. Mehra